Atomoxetine Hydrochloride contians not less than 99.0% and not more than 102.0% of C17H21NO‧HCl, calculated on the anhydrous basis.

共有 1 個藥物證書使用此成份

鹽酸托莫西汀
Atomoxetine Hydrochloride

• 申請商: 新雙隆生技股份有限公司
• 適應症: 注意力缺損/過動症 (ADHD)
• 發證日期: 2013-08-19